FDA Corrects Notice on Withdrawal of 27 Abbreviated New Drug Applications

Summary

The US Food and Drug Administration (FDA) has corrected a notice regarding the withdrawal of 27 abbreviated new drug applications (ANDAs) from multiple applicants, including Upsher-Smith Laboratories, LLC. and Hisun Pharmaceutical (Hangzhou) Co., Ltd., due to timely requests to preserve the approval of certain ANDAs.